Error loading player: No playable sources found

2060

AASLD Presidential Plenary

Date
May 18, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for DDW 2024 - Full Program On Demand
Full DDW 2024 On Demand Program available now!

SOCIETY: AASLD

Presentations:

ASSOCIATION OF GLUCAGON-LIKE PEPTIDE-1 AGONISTS WITH CIRRHOSIS AND HEPATOCELLULAR CANCER IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS IN THE ASSURE STUDY: INTERIM RESULTS
ALTERED GUT VIRAL ECOLOGY IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
EFFECT OF EMPAGLIFLOZIN ON LIVER FAT IN METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE PATIENTS WITHOUT DIABETES MELLITUS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
PROJECTED PREVALENCE OF CIRRHOSIS AND OVERT HEPATIC ENCEPHALOPATHY IN THE UNITED STATES, 2021–2030
EVALUATING THE IMPACT OF CO-EXISTING INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A LARGE COHORT RETROSPECTIVE STUDY

Moderators

Speaker Image for W Ray Kim
Stanford University
Speaker Image for Carla Brady
Duke University

Related Products

Thumbnail for AASLD Basic Science Emerging Topic Conference Day 1 $$$
AASLD Basic Science Emerging Topic Conference Day 1 $$$
SOCIETY: AASLD Join AASLD for an enlightening session where experts delve into groundbreaking research at the intersection of microbiome science and liver health…